AC Immune (ACIU) Depreciation & Amortization (CF) (2014 - 2025)

AC Immune (ACIU) has 12 years of Depreciation & Amortization (CF) data on file, last reported at -$3.1 million in Q4 2025.

• On a quarterly basis, Depreciation & Amortization (CF) fell 845.56% year-over-year to -$3.1 million in Q4 2025; TTM through Mar 2026 was -$2.2 million, a 233.35% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 0.89% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at -$3.1 million, down from $425037.2 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for ACIU reached as high as $539118.9 in Q3 2021 and fell as low as -$3.1 million in Q4 2025.
• Historically, Depreciation & Amortization (CF) has averaged $285687.3 across 5 years, with a median of $452536.6 in 2022.
• Across the five-year window, Depreciation & Amortization (CF) soared 37.14% in 2021 and plunged 845.56% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $527068.0 in 2021, then slipped by 9.01% to $479566.1 in 2022, then decreased by 1.97% to $470106.8 in 2023, then slipped by 12.83% to $409806.3 in 2024, then plunged by 845.56% to -$3.1 million in 2025.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were -$3.1 million in Q4 2025, $425037.2 in Q3 2025, and $438464.2 in Q2 2025.